Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
about
Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancerGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrImmunotherapy advances for glioblastomaControl of the immune response by pro-angiogenic factorsRosacea: The cytokine and chemokine networkSerial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironmentIs There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedHypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaRenal cell carcinoma.Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumorsThe receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.Association of increased Treg and Th17 with pathogenesis of moyamoya disease.Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapyThe chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma.Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment.Prognostic significance of interleukin 17 in cancer: a meta-analysis.Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.Inhibition of the differentiation of monocyte-derived dendritic cells by human gingival fibroblastsChronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice.Bevacizumab plus ipilimumab in patients with metastatic melanoma.Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.Trial Watch: Therapeutic vaccines in metastatic renal cell carcinomaPancreatic ductal adenocarcinoma: a review of immunologic aspects.Targeting the interleukin-6/Jak/stat pathway in human malignanciesTrial Watch: Adoptive cell transfer immunotherapy.Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in MiceMyeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma.IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagusThe tumor immunosuppressive microenvironment impairs the therapy of anti-HER2/neu antibodyEffects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.
P2860
Q26741623-0E1DAB01-FA4C-4FAA-A899-938F7C2DB78FQ26765758-CAF1A729-37EB-43C9-AEAA-1E5E2DD40934Q26776480-729BD71A-5E96-46B3-BAD8-3CE291B3D12EQ26866513-D26BA482-537F-4FFF-8307-3CC1DBC1FBE9Q27004733-A45CE555-82C4-4AC8-A483-26B28FDB10B6Q27023344-BF341C13-82EF-4667-9A78-D595AD8B1A59Q27335748-6D0E99F9-5329-4E0D-9F28-47241C95A6BEQ28072532-26653588-99C3-4685-AB61-B3FA2DDF30FDQ28076760-3D0A37BD-6404-4C00-AD4B-F6D29ACBC06BQ28084627-AEB5F6C0-B5FD-4BCA-A3C6-E4C5015816A9Q28085029-A71CEDFB-E2CF-4AF5-ABE7-4A5F56D136EBQ30235364-D1A78A09-9CBD-4972-B401-CC29F12FBEBAQ30412099-AB097D3D-21AF-4DA6-8696-5BE326AC5A24Q33709243-A3B3A0B7-821C-4575-9BCE-9FC6FC1751E5Q33780428-BF34B8E6-5D39-404B-951C-1F843E816B88Q33786677-36C5C9EA-74B4-4B80-ABF8-8007A5ACA47DQ33823191-EDDA1F8E-1C84-4975-8C46-C03D3D0B7D9BQ34316618-3CE21623-5EBF-4A9B-9659-008C58603508Q34422363-3E9A362C-25E3-4CED-99DA-EEA21ECC161EQ34447829-24060DC4-76FA-458D-9280-8BA448FE9959Q34497392-8EC676BA-9508-4737-9923-256D9B944E18Q34547722-9499AAEE-4282-42BB-ABAB-5F19457804C7Q34610964-D2CFB260-6F79-4B5B-81A1-FF18674D027AQ34926323-C6D89EE7-9C45-429F-AB8F-F4247A99F2C6Q34994724-85A7863B-EBA4-4B4B-92DA-9B58C8EF3093Q35012765-0791ECD2-F450-4E07-B1D1-E5E98D9B8250Q35753931-0E1E1DD6-D9D0-4A4E-BB8E-367C21BAAA31Q35799377-D60158C5-A3D1-40FB-9D68-B9300C422C06Q35870682-C5A22835-36AE-4250-9A04-70DA1B5D7B17Q35925127-3F294504-2F9A-43F0-9DAC-B09CE741F023Q36057432-D5E2E638-4D19-41E1-9434-1E32761EEA80Q36057441-E21DF183-A372-45CC-B6C4-C5C755DD593AQ36224057-2FCBD7E3-8184-4986-9E3A-3208B9E3F6FBQ36249314-208106AE-95FC-41B6-B54C-308E3CC29F7AQ36275124-922C41B6-068E-45BD-AFDC-3734EC0373BDQ36489379-4F079570-1A68-4469-A668-7189193A9A4BQ36524059-D8A7BE8F-96BF-44C2-B24F-6B435D4381FAQ36885478-9EA79F20-39FF-4D48-BEB0-D47CE6D2B4FFQ36923046-D1BC2233-47AF-4AD0-A4A3-7B4B43BE59A7Q37024656-3BD32B5B-4190-4668-9764-CFA5F85F6589
P2860
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@en
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@nl
type
label
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@en
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@nl
prefLabel
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@en
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@nl
P2093
P2860
P50
P1476
Angiogenesis and immunity: a b ...... ombination with immunotherapy.
@en
P2093
A Karadimou
B Maillere
F Quintin-Colonna
F Sandoval
N Merillon
P2860
P2888
P356
10.1007/S10555-011-9281-4
P577
2011-03-01T00:00:00Z